Premier Alternatives

Slingshot Biosciences

Emeryville, CA · Founded 2012 · Privately Held (backing)

Developer of engineered synthetic cells designed to speed up complex drug research. Slingshot Biosciences is based in Emeryville, CA and was founded in 2012. It was valued at $138 million at its later-stage round in Jul 2025, the last priced event on record. It has raised $49.8 million across 2 recorded rounds; the latest was a $26.2 million early-stage round in Jan 2023.

PMV mark · valuation
$138.0M
Oct 2026
Priced at
its later-stage round
Jul 2025
Total raised
$49.8M
Last round
Early Stage VC
Jan 2023

Slingshot Biosciences key facts

as of Oct 2026
  • Developer of engineered synthetic cells designed to speed up complex drug research.
  • Slingshot Biosciences is valued at approximately $138.0M as of Oct 2026, set at its later-stage round, Jul 2025; nothing has traded since, per PrivateMarketView’s mark.
  • It has raised $49.8M across 2 recorded rounds; the latest was Early Stage VC ($26.2M) in Jan 2023.
  • Notable investors include Impact Assets, ARCH Venture Partners, Anterra Capital, Jeffrey Kim, Northpond Ventures — 7 tracked in total.
  • Slingshot Biosciences has filed 4 Form Ds with the SEC since 2021, most recently Apr 2024 ($26.2M sold to 10 investors).
  • Status: Privately Held (backing).
PrivateMarketView mark
LOW confidence
$138.0M

Valued at $138.0M at its later-stage round, Jul 2025. Nothing has traded since.

set by its last priced roundas of Oct 2026question about this number?
Free account
More of Slingshot Biosciences with a free account
  • ·Watch Slingshot Biosciences: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Slingshot Biosciences funding rounds

2 rounds
Jan 2023Early Stage VC$26.2MSEC filing▮
May 2021Early Stage VC$22.9MSEC filing▮
Full funding history →

Slingshot Biosciences valuation

Slingshot Biosciences was valued at $138 million at its later-stage round in Jul 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Slingshot Biosciences raised?

Slingshot Biosciences has raised $49.8 million across 2 recorded rounds since 2021. The largest was a $26.2 million early-stage round in Jan 2023.

Slingshot Biosciences has filed 4 Form Ds with the SEC since 2021, most recently in Apr 2024 ($26.2 million sold to 10 investors).

Slingshot Biosciences investors

7 investors are on record for Slingshot Biosciences, including Impact Assets, ARCH Venture Partners, Anterra Capital and Jeffrey Kim. The early-stage round in Jan 2023 drew 10 investors.

About Slingshot Biosciences

Developer of engineered synthetic cells designed to speed up complex drug research. The company specializes in measuring or estimating the quantity and standardization to be reached with cell analysis and precisely matching the forward and side scatter of white blood cells, enabling researchers to access advanced diagnostics and therapeutics by eliminating cold-chain restrictions and developing products for neglected and rare diseases.

Sector
Healthcare
HQ
Emeryville, CA, United States
Founded
2012
Employees
70
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.